These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1159851

  • 21. Phase I study of iv mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose dimycolate.
    Vosika GJ, Gray GR.
    Cancer Treat Rep; 1983 Sep; 67(9):785-90. PubMed ID: 6883355
    [Abstract] [Full Text] [Related]

  • 22. Phase I study of intravenous mycobacterial cell wall skeleton and trehalose dimycolate attached to oil droplets.
    Vosika G, Giddings C, Gray GR.
    J Biol Response Mod; 1984 Dec; 3(6):620-6. PubMed ID: 6512562
    [Abstract] [Full Text] [Related]

  • 23. Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping.
    Ogura T, Namba M, Hirao F, Yamawaki M, Azuma I, Yamamura Y.
    Gan; 1978 Jun; 69(3):311-5. PubMed ID: 352783
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma.
    Zbar B, Hunter J, Rapp HJ, Canti G.
    Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175
    [Abstract] [Full Text] [Related]

  • 25. Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (P3).
    Vosika GJ, Schmidtke JR, Goldman A, Ribi E, Parker R, Gray GR.
    Cancer; 1979 Aug; 44(2):495-503. PubMed ID: 476567
    [Abstract] [Full Text] [Related]

  • 26. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE, Meyer TJ, Azuma I, Zbar B.
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract] [Full Text] [Related]

  • 27. Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG).
    Zbar B, Hunter JT, Rapp HJ, Canti GF.
    J Natl Cancer Inst; 1978 May; 60(5):1163-8. PubMed ID: 642033
    [Abstract] [Full Text] [Related]

  • 28. Immunotherapy of an experimental adenocarcinoma of the prostate.
    Morales A, Nickel JC, Downey J, Clark J, van der Linden I.
    J Urol; 1995 May; 153(5):1706-10. PubMed ID: 7715015
    [Abstract] [Full Text] [Related]

  • 29. Clinical immunotherapy trials of bacterial components derived from Mycobacteria and Nocardia.
    Vosika GJ.
    J Biol Response Mod; 1983 May; 2(4):321-42. PubMed ID: 6358421
    [Abstract] [Full Text] [Related]

  • 30. Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells.
    Smith HG, Harmel RP, Hanna MG, Zwilling BS, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1977 May; 58(5):1315-22. PubMed ID: 853526
    [Abstract] [Full Text] [Related]

  • 31. Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons.
    Yarkoni E, Rapp HJ.
    Infect Immun; 1978 Sep; 21(3):1029-32. PubMed ID: 361572
    [Abstract] [Full Text] [Related]

  • 32. Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer.
    Hunter JT, Ashley MP, Sukumar S, Sugimoto T, Zbar B, Rapp HJ, Yarkoni E.
    J Exp Med; 1981 Aug 01; 154(2):253-61. PubMed ID: 7264559
    [Abstract] [Full Text] [Related]

  • 33. Tumor regression caused by endotoxins and mycobacterial fractions.
    Ribi EE, Granger DL, Milner KC, Strain SM.
    J Natl Cancer Inst; 1975 Nov 01; 55(5):1253-7. PubMed ID: 173865
    [Abstract] [Full Text] [Related]

  • 34. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.
    Granger DL, Brehmer W, Brehmer W, Yamamoto K, Ribi E.
    Infect Immun; 1976 Feb 01; 13(2):543-53. PubMed ID: 770333
    [Abstract] [Full Text] [Related]

  • 35. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL, Zbar B.
    J Natl Cancer Inst; 1973 May 01; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.
    Hanna MG, Peters LC.
    Cancer; 1975 Oct 01; 36(4):1298-304. PubMed ID: 1175128
    [Abstract] [Full Text] [Related]

  • 37. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I, Kanetsuna F, Taniyama T, Yamamura Y, Hori M.
    Biken J; 1975 Mar 01; 18(1):1-13. PubMed ID: 807194
    [Abstract] [Full Text] [Related]

  • 38. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    Meyer TJ, Ribi EE, Azuma I, Zbar B.
    J Natl Cancer Inst; 1974 Jan 01; 52(1):103-11. PubMed ID: 4359409
    [No Abstract] [Full Text] [Related]

  • 39. Ultrastructure of L-phase variants isolated from a culture of Mycobacterium phlei.
    Imaeda T.
    J Med Microbiol; 1975 Aug 01; 8(3):389-95. PubMed ID: 1177288
    [Abstract] [Full Text] [Related]

  • 40. Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery.
    Hunter JT, Okuda T, Rapp HJ.
    J Natl Cancer Inst; 1977 Nov 01; 59(5):1435-9. PubMed ID: 909107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.